A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Clinical trial NCT01057589 · COMPLETED

Trial details

NCT number: NCT01057589
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms

Start date: 2010-02-01
Primary completion: 2012-02-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.